Duration of Immunity Against Pertussis After Natural Infection or Vaccination

@article{Wendelboe2005DurationOI,
  title={Duration of Immunity Against Pertussis After Natural Infection or Vaccination},
  author={Aaron M. Wendelboe and Annelies Van Rie and Stefania Salmaso and Janet A. Englund},
  journal={The Pediatric Infectious Disease Journal},
  year={2005},
  volume={24},
  pages={S58-S61}
}
Despite decades of high vaccination coverage, pertussis has remained endemic and reemerged as a public health problem in many countries in the past 2 decades. Waning of vaccine-induced immunity has been cited as one of the reasons for the observed epidemiologic trend. A review of the published data on duration of immunity reveals estimates that infection-acquired immunity against pertussis disease wanes after 4–20 years and protective immunity after vaccination wanes after 4–12 years. Further… 
Immune persistence after pertussis vaccination
TLDR
Data on immune persistence after different pertussis vaccinations is presented and the findings from countries with different vaccination strategies are compared.
Epidemiological and immunological reasons for pertussis vaccination in adolescents and adults
TLDR
Immunological and epidemiological data indicates the need for a universal booster vaccination against pertussis for adolescents and adults.
Improving pertussis vaccination
TLDR
In the short term, the introduction of cocooning vaccination is the most (cost-)effective way to reduce the pertussis burden in infants and in the long term, improved pertussedis vaccines should be developed which induce long lasting immunity.
How to fight pertussis?
  • N. Guiso
  • Medicine
    Therapeutic advances in vaccines
  • 2013
TLDR
Pertussis is one of the oldest vaccine-preventable bacterial diseases, so can provide a good illustration of all of the aspects associated with the need for surveillance after the introduction of vaccination, and any changes of vaccine type, vaccine strategy, characteristics of the disease, and biological diagnosis must not be neglected.
Live attenuated vaccines against pertussis
TLDR
Developing live attenuated vaccine candidates in order to mimic natural infection, which induces long-lasting immunity and their interesting bystander properties as powerful anti-inflammatory agents are described, which widens their potential use far beyond that for protection against whooping cough.
Rationale for pertussis booster vaccination throughout life in Europe.
TLDR
Recommendations for use of pertussis booster vaccinations at different ages are proposed to reduce individual morbidity and transmission from present rates and increase herd protection.
What is new in pertussis?
TLDR
With pertussis continuing to pose a serious threat to infants, and greatly affecting adolescents and adults, there remains a need to increase the awareness of physicians as to the growing pertussi problem, standardize diagnostic techniques, and implement various new vaccine strategies to enhance its control.
What Is Wrong with Pertussis Vaccine Immunity? The Problem of Waning Effectiveness of Pertussis Vaccines.
TLDR
Pertussis is resurgent in some countries, particularly those in which children receive acellular pertussis (aP) vaccines in early infancy and boosters later in life, and the increase appears to be the result of waning immunity.
Long-term immunity against pertussis induced by a single nasal administration of live attenuated B. pertussis BPZE1.
TLDR
Evaluated long-term immunogenicity and protective efficacy induced by a single intranasal dose of BPZE1 showed significantly higher efficacy to protect adult and infant mice against B. pertussis infection than two administrations of an acellular pert Mussis vaccine (aPV).
Imperfect vaccine-induced immunity and whooping cough transmission to infants.
TLDR
Age- and species-specific whooping cough tests and vaccine histories in Massachusetts from 1990 to 2008 indicate that the B. pertussis vaccine is not protective against disease induced by B. parapertussis, and wavelet analyses suggest that teenagers are not the most important source of transmission to infants.
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 33 REFERENCES
Epidemiological determinants of pertussis.
TLDR
Comprehensive post-licensing surveillance of the effectiveness of acellular pertussis vaccines will be essential to assess their long-term protection against both clinical disease and transmission of infection, and to determine the optimum boosting strategy.
Loss of immunity to pertussis in a rural community in Senegal.
TLDR
Long-term clinical pertussis case data from the Niakhar community in rural Senegal is presented, and estimates for the frequency of loss of immunity and the mean duration of protection are suggested, be it from natural infection or vaccine-induced.
PERTUSSIS: HERD IMMUNITY AND VACCINATION COVERAGE IN ST LUCIA
TLDR
It is suggested that with a homogeneous vaccination coverage of 80% of 2-year-old children pertussis might be eradicated from the island, and that this is a practicable experiment.
Epidemiology of pertussis in Denmark: the impact of herd immunity.
TLDR
The importance of herd immunity is stressed, and it is recommended that a fourth injection of pertussis vaccine is introduced to bring incidence rates down to the very low values found in countries with more intensive vaccination programmes.
An age-structured model for pertussis transmission.
TLDR
Computer simulations of the mathematical model between 1940 and 2040 show the changes that took place during the implementation phase of the U.S. program and predict only minor future changes in the age distribution and incidence of pertussis if the vaccination program is maintained at the 1995 level.
Declining pertussis incidence in Sweden following the introduction of acellular pertussis vaccine.
TLDR
The data suggest that unimmunised infants and children who have received only one dose of pertussis vaccine were provided some protection, and the decline is most obvious from the second dose onwards and remained stable for 4-5 years after the third dose in the absence of any booster dose.
Age-specific efficacy of pertussis vaccine during epidemic and non-epidemic periods.
A national survey was conducted of 3150 notified cases of whooping cough in order to determine age-specific pertussis vaccine efficacy by the 'screening' method. The cases were collected over two
Levels of anti-pertussis antibodies related to protection after household exposure to Bordetella pertussis.
TLDR
Logistic regression analyses demonstrated statistically significant correlations between clinical protection and the presence of IgG antibodies against pertactin, fimbriae 2/3 and pertussis toxin in pre-exposure sera.
Immunologic and epidemiologic experience of vaccination with a monocomponent pertussis toxoid vaccine.
TLDR
The conclusion is that PTox is both an essential and alone sufficient antigen in acellular pertussis vaccines and PTox-induced immunity to pertussi occurs both on an individual and community basis.
Epidemiology of pertussis in a West African community before and after introduction of a widespread vaccination program.
TLDR
A prospective cohort of children in a rural West African community over a 13-year period comprising time before and after introduction of a vaccination program suggests a strong herd-immunity effect of pertussis.
...
1
2
3
4
...